AU Patent

AU2021266229B2 — Intrauterine contraceptive device

Assigned to Sebela Vlc Ltd · Expires 2023-06-29 · 3y expired

What this patent protects

H:\Kzh\Interwoven\NRPortbl\DCC\KZH\6272568_I.doex-10/01/2018 ABSTRACT A method for promoting contraception by placing a contraceptive device within a uterus without blocking fallopian tubes may involve advancing a distal end of a delivery device through a cervix, advancing th…

USPTO Abstract

H:\Kzh\Interwoven\NRPortbl\DCC\KZH\6272568_I.doex-10/01/2018 ABSTRACT A method for promoting contraception by placing a contraceptive device within a uterus without blocking fallopian tubes may involve advancing a distal end of a delivery device through a cervix, advancing the contraceptive device comprising an elongate shape memory member out of the distal end of the delivery device and into the uterus, and limiting inferior migration of the contraceptive device within the uterus and/or device embedment within the uterus.

Drugs covered by this patent

Patent Metadata

Patent number
AU2021266229B2
Jurisdiction
AU
Classification
—
Expires
2023-06-29
Drug substance claim
No
Drug product claim
No
Assignee
Sebela Vlc Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.